<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Histochem Cytochem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Histochem. Cytochem</journal-id>
<journal-id journal-id-type="publisher-id">JHC</journal-id>
<journal-id journal-id-type="hwp">spjhc</journal-id>
<journal-title-group>
<journal-title>Journal of Histochemistry and Cytochemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-1554</issn>
<issn pub-type="epub">1551-5044</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29290138</article-id>
<article-id pub-id-type="pmc">5958378</article-id>
<article-id pub-id-type="doi">10.1369/0022155417742147</article-id>
<article-id pub-id-type="publisher-id">10.1369_0022155417742147</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Heparan Sulfate Proteoglycans as Relays of
Neuroinflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Schaefer</surname>
<given-names>Liliana</given-names>
</name>
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Frevert</surname>
<given-names>Charles W.</given-names>
</name>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-3117-5367</contrib-id>
<name>
<surname>O’Callaghan</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-0022155417742147"></xref>
<aff id="aff1-0022155417742147">Department of Medical Cell Biology, Uppsala
University, Uppsala, Sweden</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiao</given-names>
</name>
<aff id="aff2-0022155417742147">Department of Neuroscience, Uppsala University,
Uppsala, Sweden</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jin-Ping</given-names>
</name>
<aff id="aff3-0022155417742147">Department of Medical Biochemistry and
Microbiology, Uppsala University, Uppsala, Sweden</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0022155417742147">Paul O’Callaghan, Uppsala Biomedical Centre,
Husargatan 3, 751 23 Uppsala, Sweden. E-mail:
<email>paul.ocallaghan@mcb.uu.se</email></corresp>
<fn fn-type="COI-statement">
<p><bold>Competing Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>1</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2018</year>
</pub-date>
<volume>66</volume>
<issue>4</issue>
<issue-title>Special Issue on ECM Control of Innate Immunity</issue-title>
<fpage>305</fpage>
<lpage>319</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder content-type="sage">The Histochemical Society</copyright-holder>
</permissions>
<abstract>
<p>Heparan sulfate proteoglycans (HSPGs) are implicated as inflammatory mediators in
a variety of settings, including chemokine activation, which is required to
recruit circulating leukocytes to infection sites. Heparan sulfate (HS)
polysaccharide chains are highly interactive and serve co-receptor roles in
multiple ligand:receptor interactions. HS may also serve as a storage depot,
sequestering ligands such as cytokines and restricting their access to binding
partners. Heparanase, through its ability to fragment HS chains, is a key
regulator of HS function and has featured prominently in studies of HS’s
involvement in inflammatory processes. This review focuses on recent discoveries
regarding the role of HSPGs, HS, and heparanase during inflammation, with
particular focus on the brain. HS chains emerge as critical go-betweens in
multiple aspects of the inflammatory response—relaying signals between receptors
and cells. The molecular interactions proposed to occur between HSPGs and the
pathogen receptor toll-like receptor 4 (TLR4) are discussed, and we summarize
some of the contrasting roles that HS and heparanase have been assigned in
diseases associated with chronic inflammatory states, including Alzheimer’s
disease (AD). We conclude by briefly discussing how current knowledge could
potentially be applied to augment HS-mediated events during sustained
neuroinflammation, which contributes to neurodegeneration in AD.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer’s disease (AD)</kwd>
<kwd>extracellular matrix (ECM)</kwd>
<kwd>heparan sulfate (HS)</kwd>
<kwd>heparan sulfate proteoglycans (HSPGs)</kwd>
<kwd>heparanase</kwd>
<kwd>inflammation</kwd>
<kwd>innate immunity</kwd>
<kwd>microglia</kwd>
<kwd>neuroinflammation</kwd>
<kwd>toll-like receptor 4 (TLR4)</kwd>
</kwd-group>
<funding-group>
<award-group id="award1-0022155417742147">
<funding-source id="funding1-0022155417742147">
<institution-wrap>
<institution>Vetenskapsrådet</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004359</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding1-0022155417742147">2015-02595</award-id>
</award-group>
<award-group id="award2-0022155417742147">
<funding-source id="funding2-0022155417742147">
<institution-wrap>
<institution>Alzheimerfonden</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100008599 10.13039/501100008599
10.13039/501100008599</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding2-0022155417742147">AF-552581</award-id>
<award-id rid="funding2-0022155417742147">AF-554871</award-id>
<award-id rid="funding2-0022155417742147">AF-649251</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>